NDC 51662-1564
ZIPRASIDONE MESYLATE
Ziprasidone Mesylate
ZIPRASIDONE MESYLATE is a Intramuscular Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Ziprasidone Mesylate.
| Product ID | 51662-1564_c75971f8-9641-a6e8-e053-2995a90af654 |
| NDC | 51662-1564 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ZIPRASIDONE MESYLATE |
| Generic Name | Ziprasidone Mesylate |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAMUSCULAR |
| Marketing Start Date | 2021-07-17 |
| Marketing Category | ANDA / |
| Application Number | ANDA211908 |
| Labeler Name | HF Acquisition Co LLC, DBA HealthFirst |
| Substance Name | ZIPRASIDONE MESYLATE |
| Active Ingredient Strength | 20 mg/mL |
| Pharm Classes | Atypical Antipsychotic [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |